TIAA CREF Investment Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.15M | Sell |
1,626
-121
| -7% | -$85.5K | ﹤0.01% | 2255 |
|
|
2018
Q4 | $817K | Sell |
1,747
-204
| -10% | -$95.4K | ﹤0.01% | 2356 |
|
|
2018
Q3 | $1.68M | Buy |
1,951
+314
| +19% | +$271K | ﹤0.01% | 2212 |
|
|
2018
Q2 | $1.13M | Sell |
1,637
-135
| -8% | -$93K | ﹤0.01% | 2445 |
|
|
2018
Q1 | $790K | Hold |
1,772
| – | – | ﹤0.01% | 2541 |
|
|
2017
Q4 | $781K | Sell |
1,772
-2,301
| -56% | -$1.01M | ﹤0.01% | 2583 |
|
|
2017
Q3 | $2.01M | Sell |
4,073
-3,849
| -49% | -$1.9M | ﹤0.01% | 2164 |
|
|
2017
Q2 | $4.39M | Buy |
7,922
+316
| +4% | +$175K | ﹤0.01% | 1678 |
|
|
2017
Q1 | $5.04M | Buy |
7,606
+174
| +2% | +$115K | ﹤0.01% | 1587 |
|
|
2016
Q4 | $2.49M | Buy |
7,432
+2,960
| +66% | +$990K | ﹤0.01% | 2062 |
|
|
2016
Q3 | $1.34K | Buy |
4,472
+745
| +20% | +$224 | ﹤0.01% | 2381 |
|
|
2016
Q2 | $645K | Buy |
3,727
+870
| +30% | +$151K | ﹤0.01% | 2757 |
|
|
2016
Q1 | $640K | Hold |
2,857
| – | – | ﹤0.01% | 2696 |
|
|
2015
Q4 | $1.73M | Buy |
2,857
+74
| +3% | +$44.9K | ﹤0.01% | 2255 |
|
|
2015
Q3 | $1.43M | Buy |
2,783
+51
| +2% | +$26.2K | ﹤0.01% | 2350 |
|
|
2015
Q2 | $1.2M | Buy |
2,732
+1,334
| +95% | +$584K | ﹤0.01% | 2612 |
|
|
2015
Q1 | $506K | Buy |
1,398
+263
| +23% | +$95.2K | ﹤0.01% | 2916 |
|
|
2014
Q4 | $407K | Sell |
1,135
-14
| -1% | -$5.02K | ﹤0.01% | 3011 |
|
|
2014
Q3 | $347K | Sell |
1,149
-70
| -6% | -$21.1K | ﹤0.01% | 3035 |
|
|
2014
Q2 | $747K | Buy |
1,219
+556
| +84% | +$341K | ﹤0.01% | 2886 |
|
|
2014
Q1 | $444K | Buy |
+663
| New | +$444K | ﹤0.01% | 2973 |
|